VSEE HEALTH, INC. — Form 8-K
Filed July 7, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 72/100
What the filing says
VSee Health issued two convertible promissory notes totaling $507,000 in principal ($250K net from ClearThink Capital Partners, LLC dated June 17, 2026; $257K net from Vanquish Funding Group Inc. dated June 18, 2026). Both notes convert to common stock at 85% and 75% of 10-day VWAP respectively, with maturity in 12 months, monthly payments, 10-22% interest, and 120-150% default multipliers. As of June 2026, company had 47.3–48.6M shares outstanding (100M authorized). Placement agent Spartan Capital received $25K; legal/due diligence fees of $12K reimbursed to lenders.
Why this rating
Two convertible debt raises ($507K gross) represent ~2.8% of $18.2M market cap—material for a micro-cap. Aggressive terms (85-75% VWAP discount, 120-150% default penalties, high interest 10-22%, cross-default clauses, most-favored-nations) signal distressed financing. Combined with capital dilution risk upon conversion and monthly payment obligations, this materially constrains financial flexibility and increases near-term default risk.
See more from July 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.